Proportion of thyroid cancer and other cancers in the democratic republic of Congo.
Africa
Cancer
Democratic Republic of the Congo
Papillary carcinoma
Proportion
Thyroid cancer
Journal
World journal of experimental medicine
ISSN: 2220-315X
Titre abrégé: World J Exp Med
Pays: United States
ID NLM: 101618808
Informations de publication
Date de publication:
20 Jun 2023
20 Jun 2023
Historique:
received:
04
03
2023
revised:
15
05
2023
accepted:
22
05
2023
medline:
3
7
2023
pubmed:
3
7
2023
entrez:
3
7
2023
Statut:
epublish
Résumé
Cancer diagnosis is increasing around the world and in the Democratic Republic of the Congo (DRC). The proportion of thyroid cancer has increased over the past three decades. There are very few studies on cancer epidemiology, and in particular on thyroid cancer in the DRC. To establish the most recent proportion of thyroid cancer in the DRC compared to other cancers. This is a retrospective and descriptive study of 6106 consecutive cancer cases listed in the pathological registers of 4 Laboratories in the city of Kinshasa. This study included all cancer cases recorded in the registers between 2005 and 2019. From a sample of 6106 patients, including all cancer types, 68.3% cases were female and 31.7% were male. Breast and cervical cancer were the most common types of cancer in women and, prostate and skin cancer were the most common types in men. Thyroid cancer was sixth in proportion in women and eleventh in men compared to all cancers. Papillary carcinoma was the most common of thyroid cancers. Rare cancers such as anaplastic and medullary thyroid carcinomas had a proportion of 7% and 2%, respectively. Newer diagnostic tools led to a surge in cancer diagnoses in the DRC. Thyroid cancer has more than doubled its proportion over the last several decades in the country.
Sections du résumé
BACKGROUND
BACKGROUND
Cancer diagnosis is increasing around the world and in the Democratic Republic of the Congo (DRC). The proportion of thyroid cancer has increased over the past three decades. There are very few studies on cancer epidemiology, and in particular on thyroid cancer in the DRC.
AIM
OBJECTIVE
To establish the most recent proportion of thyroid cancer in the DRC compared to other cancers.
METHODS
METHODS
This is a retrospective and descriptive study of 6106 consecutive cancer cases listed in the pathological registers of 4 Laboratories in the city of Kinshasa. This study included all cancer cases recorded in the registers between 2005 and 2019.
RESULTS
RESULTS
From a sample of 6106 patients, including all cancer types, 68.3% cases were female and 31.7% were male. Breast and cervical cancer were the most common types of cancer in women and, prostate and skin cancer were the most common types in men. Thyroid cancer was sixth in proportion in women and eleventh in men compared to all cancers. Papillary carcinoma was the most common of thyroid cancers. Rare cancers such as anaplastic and medullary thyroid carcinomas had a proportion of 7% and 2%, respectively.
CONCLUSION
CONCLUSIONS
Newer diagnostic tools led to a surge in cancer diagnoses in the DRC. Thyroid cancer has more than doubled its proportion over the last several decades in the country.
Identifiants
pubmed: 37396884
doi: 10.5493/wjem.v13.i3.17
pmc: PMC10308319
doi:
Types de publication
Journal Article
Langues
eng
Pagination
17-27Informations de copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict-of-interest statement: There are no conflicts of interest to report.
Références
N Engl J Med. 2004 Oct 21;351(17):1764-71
pubmed: 15496625
Pan Afr Med J. 2015 May 26;21:59
pubmed: 26405495
Thyroid. 2009 Apr;19(4):333-40
pubmed: 19355823
Nat Rev Endocrinol. 2020 Jan;16(1):17-29
pubmed: 31616074
Biomedicines. 2020 Jul 21;8(7):
pubmed: 32708265
Endocrinol Metab Clin North Am. 2019 Mar;48(1):23-35
pubmed: 30717905
Pan Afr Med J. 2019 May 31;33:73
pubmed: 31448035
Health Rep. 2020 Jan 15;31(1):15-25
pubmed: 31940149
Front Genet. 2012 Nov 28;3:268
pubmed: 23226157
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1092-100
pubmed: 19293311
Cancer Causes Control. 2009 Jul;20(5):525-31
pubmed: 19016336
Front Public Health. 2022 Sep 28;10:974359
pubmed: 36249201
J Saudi Heart Assoc. 2012 Apr;24(2):145
pubmed: 23960685
Clin Cancer Res. 2019 Aug 1;25(15):4603-4610
pubmed: 30890551
Cancer Causes Control. 2009 Feb;20(1):75-86
pubmed: 18766448
Epidemiol Prev. 2008 May-Jun;32(3):136
pubmed: 18828550
Pan Afr Med J. 2016 Mar 15;23:88
pubmed: 27222685
Eur J Endocrinol. 2004 Feb;150(2):133-9
pubmed: 14763910
J Natl Cancer Inst. 2005 May 18;97(10):724-32
pubmed: 15900042
Ann Endocrinol (Paris). 2011 Sep;72(4):251-281
pubmed: 21782154
Indian J Endocrinol Metab. 2011 Jul;15(Suppl 2):S78-81
pubmed: 21966658
Can Oncol Nurs J. 2017 Oct 1;27(4):375-385
pubmed: 31148733
PLoS One. 2017 Jun 14;12(6):e0179387
pubmed: 28614405
Pan Afr Med J. 2016 Mar 25;23:129
pubmed: 27279956
Breast Cancer Res Treat. 2023 Jun;199(3):511-531
pubmed: 37052762
Pan Afr Med J. 2020 Oct 05;37:120
pubmed: 33425153
Ann Endocrinol (Paris). 2010 Mar;71(2):95-101
pubmed: 20036351
East Mediterr Health J. 2013 Mar;19(3):263-70
pubmed: 23879078
Ann Endocrinol (Paris). 2008 Jun;69(3):174-80
pubmed: 18423422
Endocr Pathol. 2013 Sep;24(3):125-31
pubmed: 23666798
CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96
pubmed: 18287387
Eur J Cancer. 2021 Nov;157:308-347
pubmed: 34560371
Eur J Public Health. 2018 Aug 1;28(4):707-712
pubmed: 29741657
Cancer. 1987 Dec 15;60(12):3096-102
pubmed: 3677033
Thyroid. 2011 Apr;21(4):367-71
pubmed: 21190444
J Endocrinol Invest. 2001 Nov;24(10):770-6
pubmed: 11765046
J Clin Endocrinol Metab. 2014 Feb;99(2):E276-85
pubmed: 24248188